An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
about
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deploymentNew Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus MefloquineArtemisinin-based combination therapy for treating uncomplicated malariaAn open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in AsiaArtesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety.Thrombocytopaenia in pregnant women with malaria on the Thai-Burmese border.Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malariaPopulation pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-mefloquine in Indian patients for the treatment of acute uncomplicated Plasmodium falciparum malaria.Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved ToolTolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malariaThe story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study.Discovery, mechanisms of action and combination therapy of artemisininEarly variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance.Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.A Randomized Trial to Compare the Safety, Tolerability, and Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria in Nigerian Patients With Sickle Cell Disease.Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in Amazon basin communities.Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial.Artesunate-amodiaquine for the treatment of uncomplicated malaria.The effect of varying analytical methods on estimates of anti-malarial clinical efficacy.Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors.Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trialAbsence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum.Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire.Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum.Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report.
P2860
Q21090072-5DDDAB4C-8EC9-4BB5-BD6B-35EB1BDCAF37Q22061804-5B619DC1-8C53-4E0A-BBD3-CA5786015C27Q24241785-0DF28B94-55CE-4839-AF52-602CF0ADAEFDQ28474978-8E260E7F-02EF-4037-9584-F79C6326069DQ30478626-04830A36-BCA5-4365-A66C-0C63BF121084Q33381614-4AD19D09-475B-4FF1-9877-37F0A260117FQ33692416-F4803939-47F7-41B3-B9FB-6244DE83D4DBQ33713272-700CF897-0D1D-48F1-A91A-6152A3868BEAQ33875677-96029833-7A15-40C8-A8D7-1C199543758DQ33880614-BD14FC8D-BD5A-4F3F-9407-8D096D285081Q34329292-85E49ADE-0D23-4428-9C60-95F78FB0360FQ35006418-F0142D51-88B8-4177-BA00-36EBF11E26B8Q35154559-561842F1-DB82-48EF-92F6-0A1B87BE154DQ35834198-4C12F12E-82F3-438F-9B6D-3C224C81598EQ35882507-67E3CD3A-50F3-4C95-8343-3517D718B540Q36320208-77822729-BD05-4359-A13A-E60B037D73DCQ36561097-2D682920-773B-40B1-80A8-948B60889AC3Q36861619-A73ED3FA-FB5B-4ABA-88D3-293AB28B2C1BQ37184291-37A9F888-02CA-4074-B416-DB5A7B2EF4E3Q37200509-DFB7D120-2484-42D7-B539-D5EEF2F6169AQ37270727-CF1FA440-96C8-45EC-A5DB-77D993476643Q39402508-6A822793-2015-44F4-B88C-E9E86AE77F3EQ40338028-192ECDA5-AA3E-42E0-8B77-6DD6D45AB8F0Q41935621-FEAD625A-1ECC-4FC6-A3F3-05F6B4D90CADQ43204540-1EA3E863-7306-4434-8AF9-19183FF73212
P2860
An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
An open label randomized compa ...... alciparum malaria in Thailand.
@en
An open label randomized compa ...... alciparum malaria in Thailand.
@nl
type
label
An open label randomized compa ...... alciparum malaria in Thailand.
@en
An open label randomized compa ...... alciparum malaria in Thailand.
@nl
prefLabel
An open label randomized compa ...... alciparum malaria in Thailand.
@en
An open label randomized compa ...... alciparum malaria in Thailand.
@nl
P2093
P2860
P50
P921
P1476
An open label randomized compa ...... alciparum malaria in Thailand.
@en
P2093
Elizabeth A Ashley
Kyaw Lay Thwai
Lucy Phaiphun
Marion Barends
Nantawan Wangseang
Stephane Proux
Walter Taylor
Wattana Leowattana
Wimon Nawamaneerat
Win Htay Simon
P2860
P304
P356
10.1111/J.1365-3156.2006.01724.X
P50
P577
2006-11-01T00:00:00Z